Regulatory support from strategy through to approval and scale-up

Yes.

We often work with companies at pre-seed, seed, and Series A stage, where early regulatory decisions have the greatest impact on timelines, funding, and approval success.

Yes.

We frequently support teams experiencing delays, regulatory uncertainty, gaps in technical documentation, or feedback from Notified Bodies.

Our role is to identify the root cause and define a clear path forward.

Yes.

We support software and AI-based medical devices navigating MDR requirements and broader regulatory expectations around AI-enabled technologies.

Fractional regulatory leadership provides senior-level regulatory expertise on a flexible basis, without the cost or delay of a full-time hire.

We operate as an extension of your leadership team, helping guide strategy, submissions, stakeholder engagement, and regulatory decision-making.

Absolutely.

We regularly collaborate with internal regulatory, clinical, quality, and product teams to strengthen strategy, improve alignment, and support execution.

Yes.

We support clients in preparing for and managing interactions with Notified Bodies, including submission readiness, evidence alignment, and response strategy.

We primarily support moderate to high-risk and innovative medical devices where regulatory strategy plays a critical role in approval and commercial success.

Most engagements begin with a strategic consultation or regulatory readiness assessment.

This helps identify your current position, key risks, and the most appropriate next steps.

Yes.

We support ongoing compliance activities including post-market surveillance, PMCF, change management, and broader lifecycle regulatory strategy.